Marks Group Wealth Management’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,309
Closed -$1.25M 288
2022
Q3
$1.25M Buy
14,309
+465
+3% +$48.9K 0.19% 137
2022
Q2
$1.57M Buy
13,844
+656
+5% +$75.3K 0.23% 123
2022
Q1
$1.71M Buy
13,188
+1,182
+10% +$170K 0.21% 116
2021
Q4
$2.17M Buy
12,006
+170
+1% +$29.5K 0.26% 116
2021
Q3
$1.75M Buy
+11,836
New +$1.81M 0.24% 115

Other funds holding OMCL

Marks Group Wealth Management's OMCL Position: Q4 2022 in Review

Marks Group Wealth Management sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 14,309 shares — an estimated $1.25M sold.

Marks Group Wealth Management first reported a position in OMCL in Q3 2021 and held it in 5 quarters. The position peaked at $2.17M in Q4 2021. 329 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

  • Marks Group Wealth Management reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
  • Marks Group Wealth Management sold 14,309 Omnicell shares in Q4 2022, an estimated $1.25M.
  • Marks Group Wealth Management first reported a position in Omnicell in Q3 2021 and held it in 5 quarters.
  • Marks Group Wealth Management's Omnicell position peaked at $2.17M in Q4 2021.
  • 329 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Marks Group Wealth Management's 13F filing for Q4 2022, filed 6 Feb 2023.